Wherefore interferon?

被引:68
作者
Gresser, I
机构
[1] Laboratory of Viral Oncology, Ctr. Natl. de la Rech. Scientifique, Villejuif
[2] Laboratory of Viral Oncology, Ctr. Natl. de la Rech. Scientifique, IFC1, 94801 Villejuif Cedex
关键词
antitumor activity; induction of disease; effect on immune system; clinical use;
D O I
10.1002/jlb.61.5.567
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interferon (IFN) was discovered by virologists interested in the phenomenon of viral interference and for many years was considered to be exclusively an antiviral substance, In time, it was accepted that the antiviral action was only one manifestation of the multiple effects of IFN on cells, IFN was shown to inhibit the development of tumors, to modulate immune function, and even to induce disease, Some aspects of these phenomena will be discussed, Despite this plethora of biological effects of type I IFN, the potency of its antiviral action, combined with its varied effects on both the cell-mediated and humoral immune response, render it a most effective and remarkable antiviral substance, Arguments will be presented to support the hypothesis that the major role of IFN is, after all, in antiviral defense, Finally, the use of type I IFN in the treatment of patients with viral and neoplastic diseases and even diseases of varied and unknown etiology is discussed.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 109 条
  • [61] LOCALIZATION OF ALPHA-INTERFERON IN THE HUMAN FETOPLACENTAL UNIT
    HOWATSON, AG
    FARQUHARSON, M
    MEAGER, A
    MCNICOL, AM
    FOULIS, AK
    [J]. JOURNAL OF ENDOCRINOLOGY, 1988, 119 (03) : 531 - &
  • [62] ENHANCEMENT OF PHAGOCYTOSIS BY INTERFERON-CONTAINING PREPARATIONS
    HUANG, K
    DONAHOE, RM
    GORDON, FB
    DRESSLER, HR
    [J]. INFECTION AND IMMUNITY, 1971, 4 (05) : 581 - &
  • [63] INTERFERON EXPRESSION IN THE PANCREASES OF PATIENTS WITH TYPE-I DIABETES
    HUANG, XJ
    YUAN, J
    GODDARD, A
    FOULIS, A
    JAMES, RFL
    LERNMARK, A
    PUJOLBORRELL, R
    RABINOVITCH, A
    SOMOZA, N
    STEWART, TA
    [J]. DIABETES, 1995, 44 (06) : 658 - 664
  • [64] VIRUS INTERFERENCE .1. THE INTERFERON
    ISAACS, A
    LINDENMANN, J
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1957, 147 (927): : 258 - 267
  • [65] ISAACS A, 1961, B SCHWEIZ AKAD MED, V17, P477
  • [66] A BRIEF-HISTORY OF THE USE OF INTERFERONS AS TREATMENT OF MULTIPLE-SCLEROSIS
    JACOBS, L
    JOHNSON, KP
    [J]. ARCHIVES OF NEUROLOGY, 1994, 51 (12) : 1245 - 1252
  • [67] SENSITIZED T-LYMPHOCYTES RENDER DBA/2 BEIGE MICE RESPONSIVE TO IFN ALPHA/BETA THERAPY OF FRIEND-ERYTHROLEUKEMIA VISCERAL METASTASES
    KAIDO, T
    GRESSER, I
    MAURY, C
    MAUNOURY, MT
    VIGNAUX, F
    BELARDELLI, F
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (03) : 475 - 481
  • [68] SUCCESSFUL IMMUNOTHERAPY OF THE HIGHLY METASTATIC MURINE ESB LYMPHOMA WITH SENSITIZED CD8+ T-CELLS AND IFN-ALPHA/BETA
    KAIDO, T
    MAURY, C
    SCHIRRMACHER, V
    GRESSER, I
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (04) : 538 - 543
  • [69] KAIDO TJ, 1995, CANCER RES, V55, P6133
  • [70] THE ANTIVIRAL EFFECTS OF THE INTERFERONS AND THEIR INHIBITION
    KERR, IM
    STARK, GR
    [J]. JOURNAL OF INTERFERON RESEARCH, 1992, 12 (04): : 237 - 240